Smoking is a known predisposing factor to exacerbations in CF patients. But the effects of second-hand tobacco smoking are not yet clear. Hence, this study determined the clinical and spirometric presentations and urinary cotinine levels among cystic fibrosis patients over seven years of age in relation to their parent's smoking history.
INTRODUCTION
Cystic fibrosis (CF) is the most common hereditary respiratory disease of childhood with autosomal-dominant pattern of transition and increasing trend of incidence (1) (2) (3) . The subjects with CF and their caregivers and families usually have a decreased quality of life (4) (5) (6) (7) . Also, high economic costs and other socio-cultural conflicts may be seen in families with affected members (8) (9) (10) (11) .
The available therapeutic approaches are generally conservative and complete cure for these patients is not accessible (12) (13) (14) (15) . Accordingly, preparing optimal situations to develop better life status in patients with CF is essential (16, 17) . Determination of the factors contributing to both mental and somatic health status is important (18 in CF patients (19, 20) , but the effects of second-hand smoking are not yet clear. Hence, this study determined the clinical and spirometric presentations and urinary cotinine levels among cystic fibrosis patients over seven years of age according to their parent's smoking history.
MATERIALS AND METHODS
In this cross-sectional comparative study, 58 consecutive cystic fibrosis patients older than seven years of age were enrolled. These patients were divided into two equal groups: those with second-hand smoking and those without. . Chi-square, Kendall, and independent-sample t-tests were used; P values less than 0.05 were considered statistically significant.
RESULTS
The age, sex, BMI, family history of pulmonary disease, and relative status of parents were the same across the groups (Table 1) . Only fathers were smokers, smoking 5.9±9.9 packs per year. The symptoms, CT scan findings were similar across the groups (P>0.05) ( Tables 2 and 3 ). In the study by Raju et al. (22) , it was reported that Acrolein present in cigarette smoke could cause systemic dysfunction of cystic fibrosis transmembrane conductance regulator in extrapulmonary tissues. Rasmussen et al. (23) reported that cigarette smoke-induced Ca2+ release is the main cause of this systemic dysfunction.
The study by Campbell et al. (24) demonstrated that second-hand smoking was significantly associated with poorer spirometric results and a five-fold increase in the rate of hospitalization during the previous year. Their findings are similar to our study: the increase in the hospitalization rate in our report was two-fold in the control group. Kovesi et al. (25) reported that patients without passive smoking had higher spirometric measurements than subjects with second-hand smoking but, contrary to our findings, the difference was not statistically significant. lower than in the control subjects. Ortega-Garcia et al. (27) found that active smoking by pregnant mothers was associated with significantly lower spirometric measurements in young CF patients.
From our findings, it may be concluded that pulmonary function tests and hospital admission rates in patients with cystic fibrosis are associated with urinary cotinine levels and household second-hand smoking.
However, further multi-center studies with larger sample sizes are required to attain more definitive results. Also from our findings, it is recommended that tobacco cessation and prevention programs be integrated as an important component for parents with CF children.
